2009PubMedRequires access

Treatment failure gout.

Saman Ali, Edward V. Lally

Open publisher page 11 citations

Abstract

Treatment options for gout are well established and reasonably effective.1 They include anti-inflammatory agents such as non-steroidal anti-inflammatory drugs (NSAIDS), glucocorticoids and colchicine and urate-lowering therapies such as allopurinol and probenecid. However, despite the availability of effec-tive urate-lowering therapy, there remains a subset of patients with gout who, de-spite aggressive therapy, have intractable disease, manifest as recurrent gout flares, chronic arthritis and progressive topha-ceous deposits. These patients are referred to as having “refractory gout ” or “treat-

About this research paper

What this paper is about

Treatment options for gout are well established and reasonably effective.1 They include anti-inflammatory agents such as non-steroidal anti-inflammatory drugs (NSAIDS), glucocorticoids and colchicine and urate-lowering therapies such as allopurinol and probenecid. However, despite the availability of effec-tive urate-lowering therapy, there remains a subset of patients with gout who, de-spite aggressive therapy, have intractable disease, manifest as recurrent gout flares, chronic arthritis and progressive topha-ceous deposits. These patients are referred to as having “refractory gout ” or “treat-

Why it matters

OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Treatment options for gout are well established and reasonably effective.1 They include anti-inflammatory agents such as non-steroidal anti-inflammatory drugs (NSAIDS), glucocorticoids and colchicine and urate-lowering therapies such as allopurinol and probenecid. However, despite the availability of effec-tive urate-lowering therapy, there remains a subset of patients with gout who, de-spite aggressive therapy, have intractable disease, manifest as recurrent gout flares, chronic arthritis and progressive topha-ceous deposits. These patients are referred to as having “refractory gout ” or “treat-

Key concepts: Febuxostat, Gout, Allopurinol, Medicine, Benzbromarone, Probenecid, Xanthine oxidase inhibitor, Xanthine oxidase

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment failure gout. — Research Paper | ScholarLens